Analyzing the Q/E CD8+ Treg Pathway to Unlock Effective Clinical Applications
Time: 9:30 am
day: Focus Day
Details:
- Unravelling the unique mechanisms of the Q/E CD8+ Treg pathway
- Detailing preclinical studies in animals and non-clinical ex vivo studies in humans
- Analyzing safety and efficacy in newly completed phase I/II clinical trials in T1D
- Exploring platforms of drug production and precision assay systems production platforms to ensure precision assay systems
